ESTRO 2024 - Abstract Book

S2885

Interdiscplinary - Other

ESTRO 2024

2. Bromley HL, Petrie D, Mann GB, Nickson C, Rea D, Roberts TE. Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures. Soc Sci Med [Internet]. 2019;228(January):142–54. Available from: https://doi.org/10.1016/j.socscimed.2019.03.028 3. Yang Z, Purba F, Wong E, Lam H, Lin H, Jo M. Do health preferences differ among Asian populations ? A comparison of EQ- 5D-5L Discrete Choice Experiments data from 11 Asian studies. :1–11. 4. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36. 5. Ho PJ, Gernaat SAM, Hartman M, Verkooijen HM. Health-related quality of life in Asian patients with breast cancer: A systematic review. BMJ Open. 2018;8(4). 6. Kaur MN, Yan J, Klassen AF, David JP, Pieris D, Sharma M, et al. A Systematic Literature Review of Health Utility Values in Breast Cancer. Med Decis Mak. 2022;0272989X2110654. 7. Pourrahmat MM, Kim A, Kansal AR, Hux M, Pushkarna D, Fazeli MS, et al. Health state utility values by cancer stage: a systematic literature review. Eur J Heal Econ [Internet]. 2021;22(8):1275–88. Available from: https://doi.org/10.1007/s10198-021-01335-8 8. EuroQol Research Foundation. EQ-5D-5L User Guide v3.0. Computer (Long Beach Calif) [Internet]. 2019;(September):169–232. Available from: https://euroqol.org/publications/user-guides 9. Sousa H, Castro S, Abreu J, Pereira MG. A systematic review of factors affecting quality of life after postmastectomy breast reconstruction in women with breast cancer. Psychooncology. 2019;28(11):2107–18. 10. Kouwenberg CAE, De Ligt KM, Kranenburg LW, Rakhorst H, De Leeuw D, Siesling S, et al. Long-Term Health-Related Quality of Life after Four Common Surgical Treatment Options for Breast Cancer and the Effect of Complications: A Retrospective Patient-Reported Survey among 1871 Patients. Plast Reconstr Surg. 2020;1– Zehra S, Doyle F, Barry M, Walsh S, Kell MR. Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis [Internet]. Vol. 27, Breast Cancer. Springer Japan; 2020. 534–566 p. Available from: https://doi.org/10.1007/s12282-020-01076-1 12. Yoon AY, Bozzuto L, Seto AJ, Fisher CS, Chatterjee A. A Systematic Review of Utility Score Assessments in the Breast Surgery Cost-Analysis Literature. Ann Surg Oncol [Internet]. 2019;26(5):1190–201. Available from: https://doi.org/10.1245/s10434-019-07160-x 13. Guerra RL, Dos Reis NB, Corrêa FDM, Fernandes MM, Ribeiro Alves Fernandes R, Cancela MDC, et al. Breast Cancer Quality of Life and Health-state Utility at a Brazilian Reference Public Cancer Center. Expert Rev Pharmacoeconomics Outcomes Res [Internet]. 2020;20(2):185–91. Available from: https://doi.org/10.1080/14737167.2019.1621752 14. Rautenberg T, Hodgkinson B, Zerwes U, Downes M. Meta-analysis of health state utility values measured by EuroQol 5-dimensions (EQ5D) questionnaire in Chinese women with breast cancer. BMC Cancer [Internet]. 2022;22(1):1–13. Available from: https://doi.org/10.1186/s12885-021-09140-5 15. Kim S, Jo M, Lee H, Lee J. PPA-129856-estimation-of-health-state-utilities-in-breast-cancer. 2017;531–6. 16. Liu L, Li S, Wang M, Chen G. Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China. Patient Prefer Adherence. 2017;11:1049–56. 17. Lloyd A, Nafees B, Narewska J, Dewilde S, Watkins J. Health state utilities for metastatic breast cancer. Br J Cancer. 2006;95(6):683–90. 18. Efthymiadou O, Mossman J, Kanavos P. Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patients. Health Policy (New York) [Internet]. 2019;123(2):159–65. Available from: https://doi.org/10.1016/j.healthpol.2018.12.003 19. Joseph Garcia S, Vincent Uy C, Ngelangel C, Delos Reyes F. Association between Tumor Response and Change in EQ5D-3L Quality of Life among Cancer Patients. Arch Cancer Res. 2017;05(02):1–11. 20. Castillo-Carandang NT, Sison OT, Sy RG, Wee HL, Llanes EJB, Punzalan FER, et al. Establishing validity of EQ-5D-3L (Tagalog) to measure health-related quality of life states among adult Filipinos (20-50 years old). Acta Med Philipp. 2018;52(5):397–403. 21. Genuino AJ, Chaikledkaew U, Guerrero AM, Reungwetwattana T, Thakkinstian A. Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines. BMC Health Serv Res. 2019;19(1):1–12. 13. 11.